VENCLEXTA (venetoclax) tablets, for oral use. Initial U.S. Approval: 2016

FDA approved Anti-Cancer medicine VENCLEXTA (venetoclax) tablets is available upon request. Get best retail price of VENCLEXTA (venetoclax) tablets from trusted online pharmacy. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email [email protected]. For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Medical Oncologist.

VENCLEXTA (venetoclax) tablets, for oral use. Initial U.S. Approval: 2016

INDICATIONS AND USAGE
VENCLEXTA is a BCL-2 inhibitor indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test, who have received at least one prior therapy.
This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
DOSAGE FORMS & STRENGTHS
Tablets: 10 mg, 50 mg, 100 mg
Manufactured By: AbbVie Inc
Prescribing Information URL: Click Here

HOW TO MAKE AN ENQUIRY FOR VENCLEXTA (venetoclax) tablets?

FDA approved Anti-Cancer medicine VENCLEXTA (venetoclax) tablets is available upon request. Get best retail price of VENCLEXTA (venetoclax) tablets from trusted online pharmacy. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email [email protected]. For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Medical Oncologist.

In the US, venetoclax is indicated for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Indication does not depend on mutation status (e. g. 17p deletion, IGHV mutation, 12+).
In the EU, venetoclax monotherapy is indicated for the treatment of chronic lymphocytic leukaemia (CLL) in the presence of 17p deletion or TP53 mutation in adults who are unsuitable for or have failed a B cell receptor pathway inhibitor and for the treatment of CLL in the absence of 17p deletion or TP53 mutation in adults who have failed both chemoimmunotherapy and a B cell receptor pathway inhibitor.
Other types of leukemia
Venetoclax is also indicated as part of a combination therapy for acute myeloid leukemia (AML). For this purpose it is with azacitidine, decitabine, or low-dose cytarabine for newly diagnosed adults who are age 75 years or older, or those with other health problems where intensive chemotherapy cannot be used.

HOW AND WHERE TO BUY venetoclax tablets?

You can order venetoclax tablets direct from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery. To get best retail price/cost of venetoclax tablets in India, Call 8750295029 or Email [email protected]FDA approved drugs of Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.